CollPlant Ltd - Product Pipeline Analysis, 2017 Update - Product Image

CollPlant Ltd - Product Pipeline Analysis, 2017 Update

  • ID: 4372818
  • Company Profile
  • 31 pages
  • GlobalData
  • CollPlant Ltd
1 of 5

FEATURED COMPANIES

  • AGAM Biological Products
  • Regentis Biomaterials Ltd
  • MORE
Summary

CollPlant Ltd (CollPlant) is a regenerative medicine company that develops and commercializes tissue repair products. The company’s product categories include orthobiologics, wound care, and pipeline products. Its orthobiologics products comprise VergenixSTR and VergenixBVF. CollPlant’s wound care products include VergenixFG, Vergenix wound dressing. Its pipeline includes bioink, VergenixTRA, and surgical wounds. CollPlant offers tissue repair products in the areas of orthopedic applications and for advanced wound healing. The company’s products include a surgical matrix for spinal fusion and bone trauma, a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. It develops regenerative medicine by utilizing proprietary processing technologies based on recombinant human collagen and other proteins. CollPlant is headquartered in Ness Ziona, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company CollPlant Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AGAM Biological Products
  • Regentis Biomaterials Ltd
  • MORE
  • CollPlant Ltd Company Overview
  • CollPlant Ltd Company Snapshot
  • CollPlant Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • CollPlant Ltd - Pipeline Analysis Overview
  • CollPlant Ltd - Key Facts
  • CollPlant Ltd - Major Products and Services
  • CollPlant Ltd Pipeline Products by Development Stage
  • CollPlant Ltd Pipeline Products Overview
  • Absorbable Bio-active Surgical Matrix - Spinal Fusion
  • Absorbable Bio-active Surgical Matrix - Spinal Fusion Product Overview
  • Vergenix STR - Anterior Cruciate Ligament
  • Vergenix STR - Anterior Cruciate Ligament Product Overview
  • Vergenix STR - Rotator Cuff Repair
  • Vergenix STR - Rotator Cuff Repair Product Overview
  • Vergenix TRA
  • Vergenix TRA Product Overview
  • VergenixBVF
  • VergenixBVF Product Overview
  • VergenixBVF - Antibiotics
  • VergenixBVF - Antibiotics Product Overview
  • VergenixDMR
  • VergenixDMR Product Overview
  • VergenixHVR
  • VergenixHVR Product Overview
  • VergenixPBR
  • VergenixPBR Product Overview
  • CollPlant Ltd - Key Competitors
  • CollPlant Ltd - Key Employees
  • CollPlant Ltd - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • CollPlant Ltd, Recent Developments
  • May 31, 2017: CollPlant Provides Operational Update for Q1 2017
  • May 22, 2017: CollPlant Extends its European Distribution Network With Signing of New Distribution Agreement in Turkey for VergenixFG Wound Treatment
  • May 11, 2017: CollPlant Establishes a Separate Division to Focus on 3D Bio-Printing of Organs and Tissues
  • Apr 11, 2017: CollPlant Reports Positive Results From Post-Marketing Surveillance of VergenixFG
  • Mar 30, 2017: CollPlant Provides Commercial and Operational Update
  • Nov 08, 2016: CollPlant Signs Exclusive Distribution Agreement with Arthrex for VergenixSTR
  • Oct 19, 2016: CollPlant Receives CE Mark for Vergenix STR for Treatment of Tendinopathy
  • Aug 17, 2016: CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix STR for Treatment of Tendinopathy
  • May 31, 2016: CollPlant Receives Chief Scientist's Authorization for a NIS 12 Million Research and Development Projects with Funding of Approximately 50%
  • Feb 23, 2016: CollPlant Receives CE Mark for VergenixFG Wound Filler
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • CollPlant Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • CollPlant Ltd Pipeline Products by Equipment Type
  • CollPlant Ltd Pipeline Products by Indication
  • CollPlant Ltd, Key Facts
  • CollPlant Ltd, Major Products and Services
  • CollPlant Ltd Number of Pipeline Products by Development Stage
  • CollPlant Ltd Pipeline Products Summary by Development Stage
  • Absorbable Bio-active Surgical Matrix - Spinal Fusion - Product Status
  • Absorbable Bio-active Surgical Matrix - Spinal Fusion - Product Description
  • Vergenix STR - Anterior Cruciate Ligament - Product Status
  • Vergenix STR - Anterior Cruciate Ligament - Product Description
  • Vergenix STR - Rotator Cuff Repair - Product Status
  • Vergenix STR - Rotator Cuff Repair - Product Description
  • Vergenix TRA - Product Status
  • Vergenix TRA - Product Description
  • VergenixBVF - Product Status
  • VergenixBVF - Product Description
  • VergenixBVF - Antibiotics - Product Status
  • VergenixBVF - Antibiotics - Product Description
  • VergenixDMR - Product Status
  • VergenixDMR - Product Description
  • VergenixHVR - Product Status
  • VergenixHVR - Product Description
  • VergenixPBR - Product Status
  • VergenixPBR - Product Description
  • CollPlant Ltd, Key Employees
  • Glossary
List of Figures
  • CollPlant Ltd Pipeline Products by Equipment Type
  • CollPlant Ltd Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Regentis Biomaterials Ltd
  • Meytav Technological Incubator
  • AGAM Biological Products
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll